Reduced therapeutic outcomes at the conclusion of the injection cycle can be compensated by increased BT doses. Nonetheless, this impact is limited. Alternatively, interinjection intervals may be diminished. At first, interinjection intervals had been advised being not lower than 12 months.Title your collection: Name needs to be less than figures